Correction: Titmuss et al. Immune Activation Following Irbesartan Treatment in a Colorectal Cancer Patient: A Case Study. Int. J. Mol. Sci. 2023, 24, 5869

E Titmuss¹, K Milne², M R Jones¹, T Ng³, J T Topham⁴, S D Brown¹, D F Schaeffer⁴, S Kalloger³, D Wilson⁵, R D Corbett¹, L M Williamson¹, K Mungall¹, A J Mungall¹, R A Holt^{1

6}, B H Nelson^{2

6}, S J M Jones¹, J Laskin⁵, H J Lim⁵, M A Marra^{1

6}

Affiliations

¹ Canada's Michael Smith Genome Sciences Centre, BC Cancer, Vancouver, BC V5Z 4S6, Canada.
² Deeley Research Centre, BC Cancer, Victoria, BC V8R 6V5, Canada.
³ Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, BC V6T 1Z7, Canada.
⁴ Pancreas Centre BC, Vancouver, BC V5Z 1G1, Canada.
⁵ Department of Medical Oncology, BC Cancer, Vancouver, BC V5Z 4E6, Canada.
⁶ Department of Medical Genetics, University of British Columbia, Vancouver, BC V6T 1Z2, Canada.

Published Erratum

E Titmuss et al. Int J Mol Sci. 2024.

. 2024 Nov 14;25(22):12225.

doi: 10.3390/ijms252212225.

¹ Canada's Michael Smith Genome Sciences Centre, BC Cancer, Vancouver, BC V5Z 4S6, Canada.
² Deeley Research Centre, BC Cancer, Victoria, BC V8R 6V5, Canada.
³ Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, BC V6T 1Z7, Canada.
⁴ Pancreas Centre BC, Vancouver, BC V5Z 1G1, Canada.
⁵ Department of Medical Oncology, BC Cancer, Vancouver, BC V5Z 4E6, Canada.
⁶ Department of Medical Genetics, University of British Columbia, Vancouver, BC V6T 1Z2, Canada.

Abstract

The journal's Editorial Office and Editorial Board are jointly issuing a resolution and removal of the Journal Notice linked to this article [...].

Immune Activation following Irbesartan Treatment in a Colorectal Cancer Patient: A Case Study.
Titmuss E, Milne K, Jones MR, Ng T, Topham JT, Brown SD, Schaeffer DF, Kalloger S, Wilson D, Corbett RD, Williamson LM, Mungall K, Mungall AJ, Holt RA, Nelson BH, Jones SJM, Laskin J, Lim HJ, Marra MA. Titmuss E, et al. Int J Mol Sci. 2023 Mar 20;24(6):5869. doi: 10.3390/ijms24065869. Int J Mol Sci. 2023. PMID: 36982943 Free PMC article.

1. Titmuss E., Milne K., Jones M.R., Ng T., Topham J.T., Brown S.D., Schaeffer D.F., Kalloger S., Wilson D., Corbett R.D., et al. Immune Activation Following Irbesartan Treatment in a Colorectal Cancer Patient: A Case Study. Int. J. Mol. Sci. 2023;24:5869. doi: 10.3390/ijms24065869. - DOI - PMC - PubMed